| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.41 | 0.03 |